Research progress on the role of bilirubin in inflammatory bowel disease

doi:10.16352/j.issn.1001-6325.2022.12.1925

Abstract

Abstract: The role of bilirubin in inflammatory bowel disease is not only functioned as an antioxidant and anti-inflammatory factor, but also functioned in immune regulation, anti-platelet aggregation, and as inhibition factor of digestive protease and remodeling of microbiota. Serum bilirubin level is correlated with disease activity and severity, so is a potential serum marker of inflammatory bowel disease in terms of supporting clinical diagnosis and treatment of inflammatory bowel disease.

Key words: bilirubin, inflammatory bowel disease, Crohn disease, ulcerative colitis

CLC Number:

R574.6

SHI Li, YUAN Hao, LIU Min, ZHENG Ya, WANG Yu-ping, GUO Qing-hong. Research progress on the role of bilirubin in inflammatory bowel disease[J]. Basic & Clinical Medicine, 2022, 42(12): 1925-1929.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.12.1925

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I12/1925

References

[1]Dvorák A, Pospíšilová K, Žížalová K, et al. The Effects of bilirubin and lumirubin on Metabolic and oxidative stress markers[J]. Front Pharmacol,2021,12:567001.doi:10.3389/fphar.2021.567001.
[2]Tian S, Li J, Li R, et al. Decreased serum bilirubin levels and increased uric acid levels are associated with ulcerative colitis[J]. Med Sci Monit, 2018,24:6298-6304.
[3]Zhang MH, Wang HG, Shi YT, et al. Efficacy of serum total bilirubin in predicting the severity of ulcerative colitis: across-sectional study[J]. Ann Clin Lab Sci,2020,50:228-232.
[4]Shiraishi K, Furukawa S, Yagi S, et al. Association between serum bilirubin and mucosal healing among Japanese patients with ulcerative colitis: a cross-sectional study[J]. Int J Colorectal Dis,2021,36:377-382.
[5]王春莹,焦婕英,张永欢,等.溃疡性结肠炎患者血清总胆红素和尿酸水平与炎性因子的相关性研究[J].现代生物医学进展,2020,20:4726-4729.
[6]Szczeklik K, Krzysciak W, Cibor D, et al. Evaluation of plasma concentrations of selected antioxidant parameters in patients with active Crohn's disease[J]. Folia Medica Cracoviensia,2018,58:119-130.
[7]Leníček M, Duricová D, Hradsky O, et al. The relation-ship between serumbilirubin and Crohn's disease[J]. Inflamm Bowel Dis,2014,20:481-487.
[8]Ballini A, Santacroce L, Cantore S, et al. Probiotics efficacy on oxidative stress values in inflammatory bowel disease: arandomized double-blinded placebo-controlled pilot study[J]. Endocr Metab Immune Disord Drug Targets, 2019,19:373-381.
[9]Zhao X, Li L, Li X, et al. The relationship between serum bilirubin and inflammatory bowel disease[J]. Mediators Inflamm,2019,2019:5256460. doi:10.1155/2019/5256460.
[10]Maruo Y, Nakahara S, Yanagi T, et al. Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome[J]. J Gastroenterol Hepatol,2016,31:403-408.
[11]Robles RJ, Mukherjee S, Vuerich M, et al. Modulation of CD39 and exogenous APT102 correct immune dysfunction in experimental colitis and Crohn's disease[J].J Crohns Colitis,2020,14:818-830.
[12]Bourgonje AR, von Martels JZH, Bulthuis MLC, et al. Crohn's disease in clinical remission is marked by systemic oxidative stress[J].Front Physiol,2019,10:499.doi:10.3389/fphys.2019.00499.
[13]Liu J, Iwata K, Zhu K, et al. NOX1/NADPH oxidase in bone marrow-derived cells modulates intestinal barrier function[J]. Free Radic Biol Med,2020,147:90-101.
[14]Tran DT, Jeong YY, Kim JM, et al. The anti-inflam-matory role of Bilirubin on “Two-Hit” sepsis animal model[J]. Int J Mol Sci,2020,21:8650.doi:10.3390/ijms21228650.
[15]Li S, Bi Y, Wang Q, et al. Transplanted mouse liver stem cells at different stages of differentiation ameliorate concanavalin A-induced acute liver injury by modulating Tregs and Th17 cells in mice[J]. Am J Transl Res,2019,11:7324-7337.
[16]Hou L, Li H, Si S, et al. Exploring the causal pathway from bilirubin to CVD and diabetes in the UK biobank cohort study: observational findings and Mendelian randomization studies[J]. Atherosclerosis,2021,320:112-121.
[17]Arab HH, Al-Shorbagy MY, Saad MA. Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways[J]. Chem BiolInteract,2021,335:109368.doi:10.1016/j.cbi.2021.109368.
[18]Li Y, Huang B, Ye T, et al. Physiological concentrations of bilirubin control inflammatory response by inhibiting NF-κB and inflammasome activation[J]. Int Immunopharmacol,2020,84:106520. doi:10.1016/j.intimp.2020.106520.
[19]Kim TW, Kim Y, Jung W, et al. Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells[J]. J Control Release,2021,331:74-84.
[20]Zheng JD, He Y, Yu HY, et al. Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation[J]. World J Gastroenterol,2019,25:1865-1878.
[21]Wang S, Dong W, Liu L, et al. Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis[J]. Mol Carcinog,2019,58:1155-1167.
[22]Zhou S, Wang Z, He F, et al.Association of serum bilirubin in newborns affected by jaundice with gut microbiota dysbiosis[J]. J Nutr Biochem,2019,63:54-61.
[23]Borda-Molina D, Zuber T, Siegert W, et al. Effects of protease and phytase supplements on small intestinal microbiota and amino acid digestibility in broiler chickens[J]. Poult Sci,2019,98:2906-2918.
[24]Liang C, Takahashi K, Furuya K, et al. Platelets stimulate liver regeneration in a rat model of partial liver transplantation[J]. Liver Transpl,2021,27:719-734.
[25]Kundur AR, Santhakumar AB, Bulmer AC, et al. Mildly elevated unconjugated bilirubin is associated with reduced platelet activation-related thrombogenesis and inflamma-tion in Gilbert's syndrome[J]. Platelets,2017,28:779-785.